106 related articles for article (PubMed ID: 3102450)
1. The effect of imipenem/cilastatin on the aerobic faecal flora of children.
Borderon JC; Rastegar A; Laugier J; Gold F
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():121-5. PubMed ID: 3102450
[TBL] [Abstract][Full Text] [Related]
2. Impact of imipenem/cilastatin therapy on faecal flora.
Nord CE; Kager L; Philipson A; Stiernstedt G
Eur J Clin Microbiol; 1984 Oct; 3(5):475-7. PubMed ID: 6594237
[TBL] [Abstract][Full Text] [Related]
3. Impact of imipenem/cilastatin therapy on normal fecal flora.
Wexler HM; Finegold SM
Am J Med; 1985 Jun; 78(6A):41-6. PubMed ID: 3859214
[TBL] [Abstract][Full Text] [Related]
4. Cross-resistance and imipenem.
Calandra G; Ricci F; Wang C; Brown K
Lancet; 1986 Aug; 2(8502):340-1. PubMed ID: 2874348
[No Abstract] [Full Text] [Related]
5. Effect of imipenem-cilastatin therapy on fecal flora.
Welkon CJ; Long SS; Gilligan PH
Antimicrob Agents Chemother; 1986 May; 29(5):741-3. PubMed ID: 3460522
[TBL] [Abstract][Full Text] [Related]
6. [Use of imipenem-cilastatin in neonatal septicemias caused by gram-negative bacilli multiresistant to beta-lactam antibiotics].
Bompard Y; Lambert T; Gantzer A; Chastel A; Voinnesson A; Aufrant C
Pathol Biol (Paris); 1988 May; 36(5):521-4. PubMed ID: 3043351
[TBL] [Abstract][Full Text] [Related]
7. Imipenem/cilastatin: the first carbapenem antibiotic.
Lyon JA
Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of imipenem/cilastatin in patients with severe bacterial infections.
Reutter FW
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():141-4. PubMed ID: 3469186
[TBL] [Abstract][Full Text] [Related]
9. [Do imipenem and cilastatin interfere with the determination of serum creatinine?].
Dauchy F
Pathol Biol (Paris); 1988 May; 36(5):511-2. PubMed ID: 3043349
[TBL] [Abstract][Full Text] [Related]
10. Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin.
Birnbaum J; Kahan FM; Kropp H; MacDonald JS
Am J Med; 1985 Jun; 78(6A):3-21. PubMed ID: 3859213
[TBL] [Abstract][Full Text] [Related]
11. Severe gram-negative infections in neutropenic children cured by imipenem/cilastatin in combination with an aminoglycoside.
Baruchel A; Hartmann O; Andremont A; Tancrède C
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():167-73. PubMed ID: 3469190
[TBL] [Abstract][Full Text] [Related]
12. Nephroprotective effect of imipenem/cilastatin in reducing cyclosporine toxicity.
Sido B; Hammer C; Mraz W; Krombach F
Transplant Proc; 1987 Feb; 19(1 Pt 2):1755-8. PubMed ID: 3469804
[No Abstract] [Full Text] [Related]
13. Thienamycin: development of imipenen-cilastatin.
Kahan FM; Kropp H; Sundelof JG; Birnbaum J
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():1-35. PubMed ID: 6365872
[TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of imipenem/cilastatin sodium in gynecological infection].
Iwaki M; Sato H; Makinoda S; Demise M; Tabata M; Yamaguchi T; Takaoka H; Shinkai N; Okubo H; Sato H
Jpn J Antibiot; 1986 Jun; 39(6):1509-13. PubMed ID: 3463791
[TBL] [Abstract][Full Text] [Related]
15. Cilastatin does not alter superoxide dismutase activity.
Proctor RA; Textor JA
Antimicrob Agents Chemother; 1985 Nov; 28(5):691-2. PubMed ID: 3867330
[TBL] [Abstract][Full Text] [Related]
16. [Effect of aztreonam on the fecal aerobic flora in children].
Borderon JC; Rastegar A; Ramponi N; Gold F; Laugier J
Pathol Biol (Paris); 1987 May; 35(5):665-8. PubMed ID: 3112714
[TBL] [Abstract][Full Text] [Related]
17. Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis.
Pedersen SS; Pressler T; Jensen T; Rosdahl VT; Bentzon MW; Høiby N; Koch C
J Antimicrob Chemother; 1987 Jan; 19(1):101-7. PubMed ID: 3104273
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic profile of imipenem/cilastatin in normal volunteers.
Drusano GL; Standiford HC
Am J Med; 1985 Jun; 78(6A):47-53. PubMed ID: 3859215
[TBL] [Abstract][Full Text] [Related]
19. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
Calandra GB; Hesney M; Brown KR
Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
[TBL] [Abstract][Full Text] [Related]
20. Imipenem/cilastatin as secondary therapy for infections in cancer patients.
Bodey GP; Rolston K; Jones P; Alvarez ME; Fainstein V; Steelhammer L
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():161-6. PubMed ID: 3469189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
